Pediatric Nephrology

, Volume 9, Issue 2, pp 176–181 | Cite as

Effects of growth hormone on kidney function in pediatric transplant recipients

  • Blanche M. Chavers
  • Leah Doherty
  • Thomas E. Nevins
  • Marie Cook
  • Kumud Sane
Original Article


Recent evidence suggests that treatment with recombinant human growth hormone (rhGH) after a successful kidney transplant improves the growth rate of children with short stature. We prospectively investigated eight children (6 boys, 2 girls), focusing on acute rejection episodes and changes in serum creatinine levels during rhGH treatment. The children (mean age 11.6±3.4 years) received rhGH daily (0.04–0.05 mg/kg subcutaneously). Seven patients completed at least 12 months (20±8 months) of rhGH treatment. Their mean serum creatinine level was 1.3±0.7 mg/dl 12 months before, and increased to 3.4±4.2 mg/dl after 12 months of rhGH treatment, but did not achieve statistical significance (P=0.06). Their mean calculated glomerular filtration rate was 58±20 ml/min per 1.73 m2 12 months before, and decreased to 38±21 ml/min per 1.73 m2 12 months before, and decreased to 38±21 ml/min per 1.73 m2 after 12 months of rhGH treatment, but did not achieve statistical significance (P=0.08). Of the seven patients, two developed acute rejection after 5 and 6 rejection-free years; three lost their grafts and returned to dialysis. These preliminary observations describe untoward renal events in children receiving rhGH treatment after a kidney transplant.

Key words

Recombinant human growth hormone Kidney transplantation Rejection 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Chavers BM, Matas AJ, Nevins TE, Mauer SM, Sutherland DER, Payne W, Dunn D, Gillingham K, Najarian JS (1989) Results of pediatric kidney transplantation at the University of Minnesota. In: Terasaki PI (ed) Clinical transplants. UCLA Tissue Typing Laboratory, Los Angeles, pp 253–266Google Scholar
  2. 2.
    McEnery PT, Stablein DM, Arbus G, Tejani A (1992) Renal transplantation in children. A report of the North American Pediatric Renal Transplant Cooperative Study. N Engl J Med 326:1727–1732Google Scholar
  3. 3.
    Ettenger RB, Blifeld C, Prince H, Gradus DBE, Cho S, Seklya N, Salusky IB, Fine RN (1987) The pediatric nephrologist's dilemma: growth after renal transplantation and its interaction with age as a possible immunologic variable. J Pediatr 111: 1022–1025Google Scholar
  4. 4.
    Offner G, Hoyer PF, Juppner H, Krohn HP, Brodehl J (1987) Somatic growth after kidney transplantation. Beneficial effect of cyclosporine in comparison with conventional immunosuppression. Am J Dis Child 141: 541–546Google Scholar
  5. 5.
    So SKS, Chang PN, Najarian JS, Mauer SM, Simmens RL, Nevins TE (1987) Growth and development in infants after renal transplantation. J Pediatr 110: 343–350Google Scholar
  6. 6.
    Van Dop C, Jabs KL, Donohoue PA, Bock GH, Fivush BA, Harmon WE (1992) Accelerated growth rates in children treated with growth hormone after renal transplantation. J Pediatr 120: 244–250Google Scholar
  7. 7.
    Benfield MR, Parker KL, Waldo FB, Overstreet SL, Kohaut EC (1993) Treatment of growth failure in children after renal transplantation. Transplantation 55: 305–308Google Scholar
  8. 8.
    Fine RN, Yadin O, Nelson PA, Pyke-Grimm K, Boechat MI, Lippe BH, Sherman BM, Ettenger RB, Kamil E (1991) Recombinant human growth hormone treatment of children following renal transplantation. Pediatr Nephrol 5: 147–151Google Scholar
  9. 9.
    Benfield MR, Parker KL, Waldo FB, Overstreet SL, Kohaut EC (1993) Growth hormone in the treatment of growth failure in children after renal transplantation. Kidney Int 44 [Suppl 43]: S62-S64Google Scholar
  10. 10.
    Jabs K, Van Dop C, Harmon W (1993) Growth hormone treatment of growth failure among children with renal transplants. Kidney Int [Suppl] 44: S71-S75Google Scholar
  11. 11.
    Van Es A, on behalf of the European Study Group (1991) Growth hormone treatment in short children with chronic renal failure and after renal transplantation: combined data from European Clinical Trials. Acta Pediatr Scand [Suppl] 279: 42–48Google Scholar
  12. 12.
    Tönshoff B, Haffner D, Mehls O, Dietz M, Ruder H, Blum WF, Heinrich U, Stöver B (1993) Efficacy and safety of growth hormone treatment in short children with renal allografts: three year experience. Kidney Int 44: 199–207Google Scholar
  13. 13.
    Gruelich WW, Pyle SI (1959) Radiographic atlas of skeletal development of the hand and wrist, 2nd edn. Stanford University Press, StanfordGoogle Scholar
  14. 14.
    Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58: 259–263Google Scholar
  15. 15.
    Matas AJ, Sibley R, Mauer SM, Sutherland DER, Simmons RL, Najarian JS (1983) The value of needle renal allograft biopsy. A retrospective study of biopsies performed during putative rejection episodes. Ann Surg 197: 226–237Google Scholar
  16. 16.
    Hokken-Koelega ACS, Stijnen T, Ridder MAJ de, Muinck KeizerSchrama SMPF de, Wolff ED, Jong MCJW de, Donckerwolcke RA, Groothoff JW, Blum WF, Drop SLS (1994) Growth hormone treatment in growth-retarded adolescents after renal transplant. Lancet 343: 1313–1317Google Scholar
  17. 17.
    Janssen F, Van Damme-Lombaerts R, Van Dyck M, Hall M, Proesmans W, Goos G, Kinnaert P (1993) Effects of recombinant human growth hormone on graft function in renal-transplanted children and adolescents: the three-year experience of a Belgian study group. Transplant Proc 25: 1049–1050Google Scholar
  18. 18.
    Fine RN, Yadin O, Moulten L, Nelson PA, Boechat MI, Lippe B (1992) Extended recombinant human growth hormone treatment after renal transplantation in children. J Am Soc. Nephrol [Suppl] 2: S274-S283Google Scholar
  19. 19.
    Bartosh S, Kaiser B, Rezvani I, Polinsky M, Schulman S, Palmer J, Baluarte HJ (1992) Effects of growth hormone administration in pediatric renal allograft recipients. Pediatr Nephrol 6: 68–73Google Scholar
  20. 20.
    Rees L, Rigden SPA, Ward G, Price MA (1990) Treatment of short stature in renal disease with recombinant human growth hormone. Arch Dis Child 65: 856–860Google Scholar
  21. 21.
    Schwartz ID, Warady BA (1992) Cadaveric renal allograft rejection after treatment with recombinant human growth hormone. J Pediatr 121: 664–665Google Scholar
  22. 22.
    Tyden G, Berg U, Reinholt F (1990) Acute renal graft rejection after treatment with human growth hormone. Lancet 336: 1455–1456Google Scholar
  23. 23.
    Hirschberg R, Kopple JD (1987) Effects of growth hormone on GFR and renal plasma flow in man. Kidney Int 32 [Suppl 22]: S21-S24Google Scholar
  24. 24.
    Doi T, Striker LJ, Quaife C, Conti FG, Palmiter R, Behringer R, Brinster R, Striker GE (1988) Progressive glomerulosclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not in those expressing insulinlike growth factor-1. Am J Pathol 131: 398–403Google Scholar
  25. 25.
    Gershberg H, Heinemann HO, Strumpf HH (1957) Renal function studies and autopsy report in a patient with gigantism and acromegaly. J Clin Endocrinol Metab 17: 377–385Google Scholar
  26. 26.
    Kelly KW (1989) Growth hormone, lymphocytes and macrophages. Biochem Pharmacol 38: 705–713Google Scholar

Copyright information

© IPNA 1995

Authors and Affiliations

  • Blanche M. Chavers
    • 1
  • Leah Doherty
    • 1
  • Thomas E. Nevins
    • 1
  • Marie Cook
    • 1
  • Kumud Sane
    • 1
  1. 1.Department of PediatricsUniversity of Minnesota Medical CenterMinneapolisUSA

Personalised recommendations